Aparito digitises clinical trials, expediting drug development for life-limiting diseases by supporting patient-centric clinical trials. Leveraging our Atom5™ platform, trials can occur within patients’ homes, featuring disease-specific apps, and integration of ePRO, video-based COAs, and wearables. Atom5™ facilitates novel digital endpoints, enhancing the acquisition of meaningful patient-generated data for innovative medicine development. 

Aparito will utilise Atom5™ to capture and analyse varied patient-generated health data, seamlessly integrating with Interactium’s e-health platform. Leading work package 6 (WP6), our collaboration aims to develop a flexible infrastructure for wearables, ePRO, and video data, aligning with FAIR principles and adapting to current needs and future innovations.